<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Diarylpropionitrile</id>
	<title>Diarylpropionitrile - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=Diarylpropionitrile"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Diarylpropionitrile&amp;action=history"/>
	<updated>2026-04-12T10:58:06Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Diarylpropionitrile&amp;diff=49784&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Diarylpropionitrile&amp;diff=49784&amp;oldid=prev"/>
		<updated>2025-03-18T10:28:46Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:28時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49783:rev-49784 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=Diarylpropionitrile&amp;diff=49783&amp;oldid=prev</id>
		<title>bsd&gt;JWBE: removed Category:Phenols; added Category:4-Hydroxyphenyl compounds using HotCat</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=Diarylpropionitrile&amp;diff=49783&amp;oldid=prev"/>
		<updated>2024-10-21T18:43:45Z</updated>

		<summary type="html">&lt;p&gt;removed &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:Phenols&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:Phenols (存在しないページ)&quot;&gt;Category:Phenols&lt;/a&gt;; added &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:4-Hydroxyphenyl_compounds&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:4-Hydroxyphenyl compounds (存在しないページ)&quot;&gt;Category:4-Hydroxyphenyl compounds&lt;/a&gt; using &lt;a href=&quot;/w/index.php?title=WP:HC&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HC (存在しないページ)&quot;&gt;HotCat&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Short description|Chemical compound}}&lt;br /&gt;
{{Drugbox&lt;br /&gt;
| Verifiedfields = &lt;br /&gt;
| Watchedfields = &lt;br /&gt;
| verifiedrevid = &lt;br /&gt;
| IUPAC_name = 2,3-bis(4-hydroxyphenyl)propanenitrile&lt;br /&gt;
| image = Diarylpropionitrile.svg&lt;br /&gt;
| width = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Clinical data--&amp;gt;&lt;br /&gt;
| tradename = &lt;br /&gt;
| pregnancy_AU = &amp;lt;!-- A / B1 / B2 / B3 / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_US = &amp;lt;!-- A / B            / C / D / X --&amp;gt;&lt;br /&gt;
| pregnancy_category = &lt;br /&gt;
| legal_AU = &amp;lt;!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --&amp;gt;&lt;br /&gt;
| legal_CA = &lt;br /&gt;
| legal_UK = &lt;br /&gt;
| legal_US = &lt;br /&gt;
| legal_status = &lt;br /&gt;
| routes_of_administration = &lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Pharmacokinetic data--&amp;gt;&lt;br /&gt;
| bioavailability = &lt;br /&gt;
| protein_bound = &lt;br /&gt;
| metabolism = &lt;br /&gt;
| elimination_half-life = &lt;br /&gt;
| excretion =&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Identifiers--&amp;gt;&lt;br /&gt;
| CAS_number_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| CAS_number = 1428-67-7&lt;br /&gt;
| CAS_supplemental = &lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = 52XWB8Q4V8&lt;br /&gt;
| ATC_prefix = &lt;br /&gt;
| ATC_suffix = &lt;br /&gt;
| PubChem = 102614&lt;br /&gt;
| DrugBank_Ref = &lt;br /&gt;
| DrugBank = &lt;br /&gt;
| ChemSpiderID_Ref = &lt;br /&gt;
| ChemSpiderID = 92686&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!--Chemical data--&amp;gt;&lt;br /&gt;
| C=15 | H=13 | N=1 | O=2&lt;br /&gt;
| smiles = C1=CC(=CC=C1CC(C#N)C2=CC=C(C=C2)O)O&lt;br /&gt;
| StdInChI = 1S/C15H13NO2/c16-10-13(12-3-7-15(18)8-4-12)9-11-1-5-14(17)6-2-11/h1-8,13,17-18H,9H2&lt;br /&gt;
| StdInChIKey = GHZHWDWADLAOIQ-UHFFFAOYSA-N&lt;br /&gt;
| synonyms = SC-4473&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Diarylpropionitrile&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;DPN&amp;#039;&amp;#039;&amp;#039;), also known as &amp;#039;&amp;#039;&amp;#039;2,3-bis(p-hydroxyphenyl)propionitrile&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;2,3-BHPPN&amp;#039;&amp;#039;&amp;#039;), is a [[synthetic compound|synthetic]], [[nonsteroidal]], and highly [[binding selectivity|selective]] [[agonist]] of [[Estrogen receptor beta|ERβ]] ([[IC50|IC&amp;lt;sub&amp;gt;50&amp;lt;/sub&amp;gt;]] = 15 nM)&amp;lt;ref&amp;gt;{{cite web|url=http://www.sigmaaldrich.com/catalog/product/sigma/h5915?lang=en&amp;amp;region=US|title=2,3-Bis(4-hydroxyphenyl)propionitrile|website=Sigmaaldrich.com|access-date=26 April 2022}}&amp;lt;/ref&amp;gt; that is used widely in [[scientific research]] to study the function of this [[receptor (biochemistry)|receptor]].&amp;lt;ref name=&amp;quot;PlantZeleznik2014&amp;quot;&amp;gt;{{cite book| vauthors = Pfaus JG, Jone LS, Flanagan-Cato LM, Blaustein JD | chapter = Female Sexual Behavior| veditors = Plant TM, Zeleznik AJ |title=Knobil and Neill&amp;#039;s Physiology of Reproduction: Two-Volume Set| chapter-url=https://books.google.com/books?id=I1ACBAAAQBAJ&amp;amp;pg=PA2311|date=15 November 2014|publisher=Academic Press|isbn=978-0-12-397769-4|pages=2311–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid21300119&amp;quot;&amp;gt;{{cite journal | vauthors = Fex Svenningsen A, Wicher G, Lundqvist J, Pettersson H, Corell M, Norlin M | title = Effects on DHEA levels by estrogen in rat astrocytes and CNS co-cultures via the regulation of CYP7B1-mediated metabolism | journal = Neurochemistry International | volume = 58 | issue = 6 | pages = 620–4 | date = May 2011 | pmid = 21300119 | doi = 10.1016/j.neuint.2011.01.024 | s2cid = 6438705 }}&amp;lt;/ref&amp;gt; It is 70-fold more selective for ERβ over [[estrogen receptor alpha|ERα]],&amp;lt;ref&amp;gt;{{cite book | vauthors = Hwang KA, Choi KC | chapter = Endocrine-Disrupting Chemicals with Estrogenicity Posing the Risk of Cancer Progression in Estrogen-Responsive Gene |title=Advances in Molecular Toxicology| chapter-url=https://books.google.com/books?id=NSeiBQAAQBAJ&amp;amp;pg=PA16|date=5 November 2015|publisher=Academic Press|isbn=978-0-12-802430-0|pages=16–}}&amp;lt;/ref&amp;gt; and has 100-fold lower [[affinity (pharmacology)|affinity]] for [[GPER]] (GPR30) relative to [[estradiol]].&amp;lt;ref name=&amp;quot;pmid20138435&amp;quot;&amp;gt;{{cite journal | vauthors = Rossi DV, Dai Y, Thomas P, Carrasco GA, DonCarlos LL, Muma NA, Li Q | title = Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta | journal = Psychoneuroendocrinology | volume = 35 | issue = 7 | pages = 1023–33 | date = August 2010 | pmid = 20138435 | pmc = 2891004 | doi = 10.1016/j.psyneuen.2010.01.003 | url = }}&amp;lt;/ref&amp;gt; DPN produces [[antidepressant]]- and [[anxiolytic]]-like effects in animals via activation of the [[endogenous]] [[oxytocin]] system.&amp;lt;ref name=&amp;quot;pmid24631553&amp;quot;&amp;gt;{{cite journal | vauthors = Kudwa AE, McGivern RF, Handa RJ | title = Estrogen receptor β and oxytocin interact to modulate anxiety-like behavior and neuroendocrine stress reactivity in adult male and female rats | journal = Physiology &amp;amp; Behavior | volume = 129 | pages = 287–296 | date = April 2014 | pmid = 24631553 | pmc = 5802969 | doi = 10.1016/j.physbeh.2014.03.004 }}&amp;lt;/ref&amp;gt; First reported in 2001, DPN was the first selective ERβ agonist to be discovered, and was followed by [[prinaberel]] (ERB-041, WAY-202041), [[WAY-200070]], and [[8β-VE2]] in 2004, [[ERB-196]] (WAY-202196) in 2005, and certain [[phytoestrogen]]s like [[liquiritigenin]] and [[nyasol]] (&amp;#039;&amp;#039;cis&amp;#039;&amp;#039;-hinokiresinol) since 2007.&amp;lt;ref name=&amp;quot;pmid20363876&amp;quot;&amp;gt;{{cite journal | vauthors = Deroo BJ, Buensuceso AV | title = Minireview: Estrogen receptor-beta: mechanistic insights from recent studies | journal = Molecular Endocrinology | volume = 24 | issue = 9 | pages = 1703–1714 | date = September 2010 | pmid = 20363876 | pmc = 5417404 | doi = 10.1210/me.2009-0288 | doi-access = free }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
DPN is a [[racemic]] mixture of two [[enantiomer]]s, (R)-DPN and (S)-DPN. Relative to (R)-DPN, (S)-DPN has between 3- and 7-fold higher [[affinity (pharmacology)|affinity]] for ERβ and appears to have higher [[intrinsic activity]] in activating ERβ.&amp;lt;ref name=&amp;quot;pmid22122563&amp;quot;&amp;gt;{{cite journal | vauthors = Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA | title = Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands | journal = Journal of Medicinal Chemistry | volume = 55 | issue = 1 | pages = 528–537 | date = January 2012 | pmid = 22122563 | pmc = 3381613 | doi = 10.1021/jm201436k }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid19074580&amp;quot;&amp;gt;{{cite journal | vauthors = Weiser MJ, Wu TJ, Handa RJ | title = Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress | journal = Endocrinology | volume = 150 | issue = 4 | pages = 1817–1825 | date = April 2009 | pmid = 19074580 | pmc = 2659273 | doi = 10.1210/en.2008-1355 }}&amp;lt;/ref&amp;gt; However, both enantiomers have very high affinity, potency, selectivity for ERβ and efficaciously activate ERβ.&amp;lt;ref name=&amp;quot;pmid22122563&amp;quot; /&amp;gt; In any case, it has been suggested that (S)-DPN might be the preferred enantiomer to use for [[scientific research]].&amp;lt;ref name=&amp;quot;pmid22122563&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
* [[ERB-196]]&lt;br /&gt;
* [[Erteberel]]&lt;br /&gt;
* [[Menerba]]&lt;br /&gt;
* [[WAY-166818]]&lt;br /&gt;
* [[WAY-214156]]&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
[[Category:GPER agonists]]&lt;br /&gt;
[[Category:Nitriles]]&lt;br /&gt;
[[Category:4-Hydroxyphenyl compounds]]&lt;br /&gt;
[[Category:Selective ERβ agonists]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{genito-urinary-drug-stub}}&lt;/div&gt;</summary>
		<author><name>bsd&gt;JWBE</name></author>
	</entry>
</feed>